Novo Integrated Sciences Total Long Term Liabilities 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novo Integrated Sciences total long term liabilities from 2012 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Novo Integrated Sciences Total Long Term Liabilities 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novo Integrated Sciences total long term liabilities from 2012 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$21.4B
Quest Diagnostics (DGX)	$17.3B
DaVita (DVA)	$13.7B
Encompass Health (EHC)	$9.3B
Chemed (CHE)	$8.7B
Elanco Animal Health (ELAN)	$7.2B
Option Care Health (OPCH)	$5.3B
RadNet (RDNT)	$5B
Amedisys (AMED)	$3.2B
Astrana Health (ASTH)	$2.8B
LifeStance Health (LFST)	$2.6B
Addus HomeCare (ADUS)	$2.4B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$1.1B
Aveanna Healthcare Holdings (AVAH)	$1B
Atai Life Sciences (ATAI)	$208M
Daxor (DXR)	$45M
ATI Physical Therapy (ATIP)	$25M
MEDIROM Healthcare Technologies (MRM)	$19M
Psychemedics (PMD)	$14M
Ontrak (OTRK)	$10M
IMAC Holdings (BACK)	$2M